FNY Managed Accounts’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ANTH
VF
WS
FNY Managed Accounts's ANTH Position: Q1 2018 in Review
FNY Managed Accounts sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 500 shares — an estimated $747 sold.
FNY Managed Accounts first reported a position in ANTH in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.
- FNY Managed Accounts reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- FNY Managed Accounts sold 500 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $747.
- FNY Managed Accounts first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
- FNY Managed Accounts's Anthera Pharmaceuticals, Inc. position peaked at $0 in Q4 2017.
- 28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.